{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T00:17:12Z","timestamp":1794874632275,"version":"4.9.1"},"reference-count":172,"publisher":"Informa UK Limited","issue":"6","funder":[{"DOI":"10.13039\/100007921","name":"University of Pittsburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000861","name":"Burroughs Wellcome Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000861","id-type":"DOI","asserted-by":"publisher"}]},{"name":"WoodNext Foundation"},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Opinion on Therapeutic Targets"],"published-print":{"date-parts":[[2025,6,3]]},"DOI":"10.1080\/14728222.2025.2507034","type":"journal-article","created":{"date-parts":[[2025,5,15]],"date-time":"2025-05-15T01:22:39Z","timestamp":1747272159000},"page":"327-343","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":9,"title":["Therapeutic targets for pulmonary arterial hypertension: insights into the emerging landscape"],"prefix":"10.1080","volume":"29","author":[{"given":"Christopher V.","family":"Flores","sequence":"first","affiliation":[{"name":"University of Pittsburgh School of Medicine","place":["Pittsburgh, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen Y.","family":"Chan","sequence":"additional","affiliation":[{"name":"University of Pittsburgh School of Medicine","place":["Pittsburgh, USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2025,5,21]]},"reference":[{"key":"e_1_3_4_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.4402"},{"key":"e_1_3_4_4_1","doi-asserted-by":"publisher","DOI":"10.3390\/life14101265"},{"key":"e_1_3_4_5_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01095-2024"},{"key":"e_1_3_4_6_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24065850"},{"key":"e_1_3_4_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacasi.2022.04.008"},{"key":"e_1_3_4_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.10.010"},{"key":"e_1_3_4_9_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02449-2016"},{"key":"e_1_3_4_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(21)00032-1"},{"key":"e_1_3_4_11_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aao4583"},{"key":"e_1_3_4_12_1","unstructured":"Hemnes A. Interventions against insulin resistance in pulmonary arterial hypertension [internet]. clinicaltrials.gov. 2024 [cited 2025 Jan 24]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT03617458"},{"key":"e_1_3_4_13_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201809-1631LE"},{"key":"e_1_3_4_14_1","unstructured":"Papworth Hospital NHS Foundation Trust. A therapeutic open label study of Tocilizumab in the treatment of pulmonary arterial hypertension [internet]. clinicaltrials.gov. 2018 [cited 2025 Jan 24]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT02676947"},{"key":"e_1_3_4_15_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a031989"},{"key":"e_1_3_4_16_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.0000012754.72951.3D"},{"key":"e_1_3_4_17_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02341-2020"},{"key":"e_1_3_4_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3877"},{"key":"e_1_3_4_19_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.033744"},{"key":"e_1_3_4_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(15)00544-5"},{"key":"e_1_3_4_21_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200712-1807OC"},{"key":"e_1_3_4_22_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-022-02005-w"},{"key":"e_1_3_4_23_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.107.736801"},{"key":"e_1_3_4_24_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00239.2004"},{"key":"e_1_3_4_25_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00034.2007"},{"key":"e_1_3_4_26_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.124.034621"},{"key":"e_1_3_4_27_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.040629"},{"key":"e_1_3_4_28_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-017-2510-4"},{"key":"e_1_3_4_29_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000181152.65534.07"},{"key":"e_1_3_4_30_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201906-1141OC"},{"key":"e_1_3_4_31_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1236OC"},{"key":"e_1_3_4_32_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.313356"},{"key":"e_1_3_4_33_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpregu.00534.2009"},{"key":"e_1_3_4_34_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.038125"},{"key":"e_1_3_4_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2024.04.005"},{"key":"e_1_3_4_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2013.07.017"},{"key":"e_1_3_4_37_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00187310"},{"key":"e_1_3_4_38_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21239222"},{"key":"e_1_3_4_39_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.047978"},{"key":"e_1_3_4_40_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI65592"},{"key":"e_1_3_4_41_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI83361"},{"key":"e_1_3_4_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2025.03.001"},{"key":"e_1_3_4_43_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2013-0100OC"},{"key":"e_1_3_4_44_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2019-0321OC"},{"key":"e_1_3_4_45_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100310"},{"key":"e_1_3_4_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.07.192"},{"key":"e_1_3_4_47_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200311-1602OC"},{"key":"e_1_3_4_48_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep45820"},{"key":"e_1_3_4_49_1","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2019-315111"},{"key":"e_1_3_4_50_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI74773"},{"key":"e_1_3_4_51_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2017.03.011"},{"key":"e_1_3_4_52_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40259-024-00680-3"},{"key":"e_1_3_4_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2024.09.021"},{"key":"e_1_3_4_54_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaz5660"},{"key":"e_1_3_4_55_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2213558"},{"key":"e_1_3_4_56_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.123.011227"},{"key":"e_1_3_4_57_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2024277"},{"key":"e_1_3_4_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2024.107442"},{"key":"e_1_3_4_59_1","unstructured":"Keros Therapeutics. Inc. A randomized phase 2 double-blind placebo-controlled study to investigate the safety and efficacy of KER-012 in combination with background therapy in adult participants with pulmonary arterial hypertension (TROPOS study) [Internet]. clinicaltrials.gov. 2024 [cited 2025 Jan 3]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05975905"},{"key":"e_1_3_4_60_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2023.1239643"},{"key":"e_1_3_4_61_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.122.19857"},{"key":"e_1_3_4_62_1","doi-asserted-by":"publisher","DOI":"10.1161\/hc0202.101974"},{"key":"e_1_3_4_63_1","doi-asserted-by":"publisher","DOI":"10.1161\/01.RES.0000145360.16770.9f"},{"key":"e_1_3_4_64_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.123.067579"},{"key":"e_1_3_4_65_1","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00000508"},{"key":"e_1_3_4_66_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2009.00445.x"},{"key":"e_1_3_4_67_1","doi-asserted-by":"publisher","DOI":"10.1086\/683813"},{"key":"e_1_3_4_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2020.10.006"},{"key":"e_1_3_4_69_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ado7824"},{"key":"e_1_3_4_70_1","doi-asserted-by":"publisher","DOI":"10.15252\/emmm.201404511"},{"key":"e_1_3_4_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2009.08.015"},{"key":"e_1_3_4_72_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.119.316398"},{"key":"e_1_3_4_73_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-022-01905-3"},{"key":"e_1_3_4_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature14620"},{"key":"e_1_3_4_75_1","doi-asserted-by":"crossref","unstructured":"Hopley SJ Chen C-N Xie C et al. A monoclonal antibody targeting the ZIP12 transporter attenuates severe experimental pulmonary arterial hypertension. B62 a lego story: molecular building blocks in pulmonary hypertension [internet]. American Thoracic Society; 2024 [cited 2025 Feb 16]. p. A4052\u2013A4052. Available from: https:\/\/www.atsjournals.org\/doi\/10.1164\/ajrccm-conference.2024.209.1_MeetingAbstracts.A4052","DOI":"10.1164\/ajrccm-conference.2024.209.1_MeetingAbstracts.A4052"},{"key":"e_1_3_4_76_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.116.305265"},{"key":"e_1_3_4_77_1","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202009-1131OC"},{"key":"e_1_3_4_78_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.123.324138"},{"key":"e_1_3_4_79_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.838657"},{"key":"e_1_3_4_80_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.120.019091"},{"key":"e_1_3_4_81_1","doi-asserted-by":"publisher","DOI":"10.1080\/14728222.2019.1615438"},{"key":"e_1_3_4_82_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2024.04.010"},{"key":"e_1_3_4_83_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI86387"},{"key":"e_1_3_4_84_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-21-1204"},{"key":"e_1_3_4_85_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2022.3511"},{"key":"e_1_3_4_86_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00692.2021"},{"key":"e_1_3_4_87_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yjmcc.2022.08.002"},{"key":"e_1_3_4_88_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.121.057879"},{"key":"e_1_3_4_89_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25158427"},{"key":"e_1_3_4_90_1","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvt105"},{"key":"e_1_3_4_91_1","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.12742"},{"key":"e_1_3_4_92_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2019-0431OC"},{"key":"e_1_3_4_93_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.5"},{"key":"e_1_3_4_94_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202009-3481OC"},{"key":"e_1_3_4_95_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.006195"},{"key":"e_1_3_4_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejps.2013.08.004"},{"key":"e_1_3_4_97_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI96462"},{"key":"e_1_3_4_98_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02463-2020"},{"key":"e_1_3_4_99_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01448-2015"},{"key":"e_1_3_4_100_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.119.044320"},{"key":"e_1_3_4_101_1","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00004.2015"},{"key":"e_1_3_4_102_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14079"},{"key":"e_1_3_4_103_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00778-y"},{"key":"e_1_3_4_104_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-physiol-012110-142317"},{"key":"e_1_3_4_105_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tins.2021.12.004"},{"key":"e_1_3_4_106_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI169441"},{"key":"e_1_3_4_107_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep14827"},{"key":"e_1_3_4_108_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00335-017-9706-7"},{"key":"e_1_3_4_109_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-01809-y"},{"key":"e_1_3_4_110_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.adn7277"},{"key":"e_1_3_4_111_1","doi-asserted-by":"crossref","unstructured":"Alotaibi M Harvey LD Nichols WC et al. Pulmonary primary oxysterol and bile acid synthesis as a predictor of outcomes in pulmonary arterial hypertension [Internet]. 2024 [cited 2025 Feb 16: Available from: http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2024.01.20.576474","DOI":"10.1101\/2024.01.20.576474"},{"key":"e_1_3_4_112_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaw4974"},{"key":"e_1_3_4_113_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.121.319815"},{"key":"e_1_3_4_114_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.058794"},{"key":"e_1_3_4_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2015.09.049"},{"key":"e_1_3_4_116_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpath.2011.05.051"},{"key":"e_1_3_4_117_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.06.028"},{"key":"e_1_3_4_118_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201412-2291OC"},{"key":"e_1_3_4_119_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.124.070693"},{"key":"e_1_3_4_120_1","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2023.1118516"},{"key":"e_1_3_4_121_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.122.19207"},{"key":"e_1_3_4_122_1","unstructured":"Study details | the combination ambrisentan plus spironolactone in pulmonary arterial hypertension study | ClinicalTrials.Gov [internet]. [cited 2025 Feb 22]. Available from: https:\/\/www.clinicaltrials.gov\/study\/NCT02253394?term=NCT02253394&rank=1"},{"key":"e_1_3_4_123_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacbts.2023.06.014"},{"key":"e_1_3_4_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9343(99)80156-9"},{"key":"e_1_3_4_125_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(24)00226-1"},{"key":"e_1_3_4_126_1","doi-asserted-by":"publisher","DOI":"10.1177\/2045893217701438"},{"key":"e_1_3_4_127_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms252312858"},{"key":"e_1_3_4_128_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-024-01064-4"},{"key":"e_1_3_4_129_1","doi-asserted-by":"publisher","DOI":"10.1002\/pul2.12352"},{"issue":"67","key":"e_1_3_4_130_1","first-page":"OA3162","article-title":"Low systemic exposure with targeted administration of AER-901 (inhaled imatinib): results of a phase 1 clinical trial","volume":"62","author":"Burgess G","year":"2023","unstructured":"Burgess G, Edgerton D, Wood N, et al. Low systemic exposure with targeted administration of AER-901 (inhaled imatinib): results of a phase 1 clinical trial. Eur Respir Soc. 2023;62(suppl 67):OA3162.","journal-title":"Eur Respir Soc"},{"key":"e_1_3_4_131_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(24)00072-9"},{"key":"e_1_3_4_132_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02356-2021"},{"key":"e_1_3_4_133_1","unstructured":"GB002 Inc. A phase 3 randomized double-blind placebo-controlled study to evaluate the efficacy and safety of oral inhalation of seralutinib for the treatment of pulmonary arterial hypertension (PAH) [internet]. clinicaltrials.gov. 2024 [cited 2025 Jan 6]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT05934526"},{"key":"e_1_3_4_134_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.113.006167"},{"key":"e_1_3_4_135_1","unstructured":"Study details | olaparib for PAH: a multicenter clinical trial | ClinicalTrials.Gov [Internet]. [cited 2025 Feb 13: Available from: https:\/\/clinicaltrials.gov\/study\/NCT03782818?term=NCT03782818&rank=1"},{"key":"e_1_3_4_136_1","doi-asserted-by":"publisher","DOI":"10.1165\/rcmb.2012-0429OC"},{"key":"e_1_3_4_137_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2019.01.1238"},{"key":"e_1_3_4_138_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2022.12.002"},{"key":"e_1_3_4_139_1","doi-asserted-by":"publisher","DOI":"10.14744\/AnatolJCardiol.2023.3013"},{"key":"e_1_3_4_140_1","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2503087"},{"key":"e_1_3_4_141_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.111.079921"},{"key":"e_1_3_4_142_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02158-2023"},{"key":"e_1_3_4_143_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-022-03208-2"},{"key":"e_1_3_4_144_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202301-0181OC"},{"key":"e_1_3_4_145_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201007-1106OC"},{"key":"e_1_3_4_146_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abe5407"},{"key":"e_1_3_4_147_1","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.add2029"},{"key":"e_1_3_4_148_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201910-2041OC"},{"key":"e_1_3_4_149_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201812-2275OC"},{"key":"e_1_3_4_150_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202109-2182LE"},{"key":"e_1_3_4_151_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13458"},{"key":"e_1_3_4_152_1","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aba2470"},{"key":"e_1_3_4_153_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.109.916098"},{"key":"e_1_3_4_154_1","doi-asserted-by":"crossref","unstructured":"Al-Qazazi R Emon IM Potus F et al. Germline and somatic mutations in DNA methyltransferase 3A (DNMT3A) predispose to pulmonary arterial hypertension (PAH) in humans and mice: Implications for Associated PAH [internet]. 2023 [cited 2025 Feb 23]. Available from: http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2023.12.30.23300391","DOI":"10.1101\/2023.12.30.23300391"},{"key":"e_1_3_4_155_1","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0112-2023"},{"key":"e_1_3_4_156_1","doi-asserted-by":"publisher","DOI":"10.3390\/biom14050552"},{"key":"e_1_3_4_157_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCHEARTFAILURE.124.012067"},{"key":"e_1_3_4_158_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202105-1118OC"},{"key":"e_1_3_4_159_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(17)30161-3"},{"key":"e_1_3_4_160_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.122.321923"},{"key":"e_1_3_4_161_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.024602"},{"key":"e_1_3_4_162_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2022.08.2230"},{"key":"e_1_3_4_163_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27326-0"},{"key":"e_1_3_4_164_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30409-0"},{"key":"e_1_3_4_165_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-76359-w"},{"key":"e_1_3_4_166_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.313911"},{"key":"e_1_3_4_167_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2023.05.006"},{"key":"e_1_3_4_168_1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00192-2024"},{"key":"e_1_3_4_169_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.05.075"},{"key":"e_1_3_4_170_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2022.09.013"},{"key":"e_1_3_4_171_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-55933-8"},{"key":"e_1_3_4_172_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11886-024-02157-9"},{"key":"e_1_3_4_173_1","unstructured":"Aria CV Inc. An early feasibility study assessing treatment of pulmonary hypertension using the aria CV pulmonary hypertension system [internet]. clinicaltrials.gov. 2023 [cited 2025 Jan 23]. Available from: https:\/\/clinicaltrials.gov\/study\/NCT04555161"},{"key":"e_1_3_4_174_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jchf.2024.05.017"}],"container-title":["Expert Opinion on Therapeutic Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/14728222.2025.2507034","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,2]],"date-time":"2025-06-02T03:17:42Z","timestamp":1748834262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/14728222.2025.2507034"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,21]]},"references-count":172,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,3]]}},"alternative-id":["10.1080\/14728222.2025.2507034"],"URL":"https:\/\/doi.org\/10.1080\/14728222.2025.2507034","relation":{},"ISSN":["1472-8222","1744-7631"],"issn-type":[{"value":"1472-8222","type":"print"},{"value":"1744-7631","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,21]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iett20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=iett20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2025-02-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-13","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-05-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}